Home > Insider Trading > Filing (0001209191-18-059054)

Filing Details

Accession Number:: 0001209191-18-059054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-16 18:34:35
Reporting Period:: 2018-11-15

Accepted Time:: 2018-11-16 18:34:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628738	Audentes Therapeutics Inc.	BOLD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238401	G Louis Lange	C/O Audentes Therapeutics, Inc. 600 California Street, 17Th Floor San Francisco CA 94108		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-11-15	20,000	$22.49	345,799	No	4	S	Direct
Common Stock	Disposition	2018-11-15	4,000	$22.49	3,555	No	4	S	Indirect	By Adrienne M. MacMillan Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Adrienne M. MacMillan Revocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,678	Indirect	By Amygdala Lange Trust
Common Stock	1,558	Indirect	By Lange Minor's Trust
Common Stock	42,343	Indirect	By Asset Management Ventures Fund, L.P.

Footnotes

The reporting person contributed shares of the Issuer's common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer's common stock was valued at $22.49 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.
The reporting person's spouse is the trustee of the Adrienne M. MacMillan Revocable Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
The reporting person's spouse is the trustee of the Amygdala Lange Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
The reporting person's spouse is the trustee of the Lange Minor's Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
The reporting person is a general partner of Asset Management Ventures Fund, L.P. ("AMVF L.L.P."), and has shared voting and dispositive power over the shares held by AMVF L.L.P. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.